Progressive MS Teleconference Recording Now Available
September 12, 2014
DEALING WITH THE EMOTIONS OF LIVING WITH PROGRESSIVE MS
Those with progressive MS suffer from Mood and Anxiety Disorders at the rate of 3-4x that of the general population. Behavioral medicine is often an important and necessary component in the interdisciplinary treatment of MS. Patients and family members might find the disease difficult to fathom, as they may feel that hopes, dreams, and goals for the future will drastically change. Individuals and family members may react in a number of different ways, including, but not limited to: grief, anxiety, anger, depression, fear, numbness, denial, hopelessness, and in the worst case suicidal ideation or intent. This program will cover the important psychological factors associated with Progressive MS as well as methods for treatment.
Amy Burleson Sullivan, PsyD, is a health psychologist, and director of behavioral medicine, fellowship training and research at Cleveland Clinic’s Mellen Center for Multiple Sclerosis Treatment and Research. Dr. Sullivan’s specialty interests include consultation-liaison work, individual and family chronic disease management, pain management, depression and adjustment to phases of life.
About the Virginia - West Virginia Chapter of the National Multiple Sclerosis (MS) Society
The Virginia - West Virginia Chapter of the National MS Society provides comprehensive programs and advocacy to assist and empower the more than 12,000 individuals with multiple sclerosis residing throughout Virginia and West Virginia, as well as three counties in northeastern North Carolina and seven counties in southeastern Kentucky. The Virginia - West Virginia Chapter is also a driving force of research for the prevention, treatment and cure of MS and contributes funds to support National MS Society research projects worldwide. The Chapter has offices in Richmond, VA; Virginia Beach, VA; Charlottesville, VA; and Charleston, WV.
About Multiple Sclerosis
Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.